Next-Generation Gynecological Cancer Diagnostics Market Growth and Forecast Report, 2030

According to P&S Intelligence, the global next-generation gynecological cancer diagnostics market is projected to hit US$ 5,135 million by 2030.
 
NEW YORK - Feb. 5, 2024 - PRLog -- The next-generation gynecological cancer diagnostics market is set to reach USD 5,135 million by 2030, powering at a rate of 10% in the years to come. This is because of the increasing prevalence of changes in lifestyle and obesity in women, gynecological malignancies, growing cases of menopause issues, and the rising incidence of diabetes.

The next-generation sequencing category dominated the industry in 2022, and it will continue like this in the years to come. This is because of the possibility of NGS for identifying genetic alteration, actionable with targeted therapy.

NGS has a possibility of 33.4% in recognizing gynecologic cancers and a high clinical action rate. With the inordinate clinical utility of NGS, testing also can improve survival for people received targeted treatment.

The uterine cancer category was the leader of the pack, with over 30%, in 2022, and it is will maintain its dominance in the years to come as well. This has a lot to do with the increasing cases of uterine cancer globally, as a result of the rising elderly women populace, increasing menopause matters after 55, the growing frequency of high sugar levels and BP, rising conditions of overweight or obesity and high estrogen levels.

Browse detailed report analysis on Next-Generation Gynecological Cancer Diagnostics Industry Growth and Forecast Report, 2030 (https://www.psmarketresearch.com/market-analysis/next-gen...)

North American next-generation gynecological cancer diagnostics market dominated the industry with a share of over 40%, in 2022, and it will grow at a healthy rate in the future. The main reason for this is the increasing cases of gynecological and cervical malignancies.

The increasing cases of gynecological cancer cases in women, all over the globe has a positive impact on next-generation gynecological cancer diagnostics solutions, and this trend will continue in the near future as well.

Contact
Vijay Kumar
***@psmarketresearch.com
End
Source: » Follow
Email:***@psmarketresearch.com
Posted By:***@psmarketresearch.com Email Verified
Tags:Cancer Diagnostics
Industry:Health
Location:New York City - New York - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
P&S Intelligence PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share